Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweigh… (NCT07480109) | Clinical Trial Compass
RecruitingNot Applicable
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
United States75 participantsStarted 2026-06-01
Plain-language summary
Middle-aged women with (overweight/)obesity who will begin or have begun GLP-1 medication use will be recruited to complete a 12-week diet intervention study. For 12-weeks, participants will continue to take their GLP-1 medication and may be provided with protein-rich foods to consume every day. Body composition, eating behavior, health, and well-being will be measured before and after the study.
Who can participate
Age range
30 Years – 60 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult women (30-60 years)
* Having overweight or obesity (BMI \>25 kg/m2)
* Prescribed or taking GLP-1 medicine (within 4 weeks) by a physician
* Willing and able to maintain current inactivity patterns throughout the study
* Willing and able to follow all study procedures
* Generally healthy, as assessed from the medical history questionnaire
Exclusion Criteria:
* Adults (\<30 years or \>60 years)
* Having normal weight (BMI \<25 kg/m2)
* Not prescribed GLP-1 medication by a physician
* Those on GLP-1 medication longer than 4 weeks (during time of screening)
* Currently on a high-protein or other specific diet
* Unwilling and/or unable to maintain current inactivity patterns throughout the study
* Unwilling and/or unable to follow all study procedures
* Unwilling and/or unable to eat pork (for the GLP-1 + Protein group)
* Not generally healthy, as assessed from the medical history questionnaire
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.